| Literature DB >> 24074126 |
Erica K Brockmeier1, Fahong Yu, David Moraga Amador, Timothy A Bargar, Nancy D Denslow.
Abstract
BACKGROUND: The eastern mosquitofish (Gambusia holbrooki) has the potential to become a bioindicator organism of endocrine disrupting chemicals (EDCs) due to its androgen-driven secondary sexual characteristics. However, the lack of molecular information on G. holbrooki hinders its use as a bioindicator coupled with biomarker data. While traditional gene-by-gene approaches provide insight for biomarker development, a holistic analysis would provide more rapid and expansive determination of potential biomarkers. The objective of this study was to develop and utilize a mosquitofish microarray to determine potential biomarkers of subchronic androgen exposure. To achieve this objective, two specific aims were developed: 1) Sequence a G. holbrooki cDNA library, and 2) Use microarray analysis to determine genes that are differentially regulated by subchronic androgen exposure in hepatic tissues of 17β-trenbolone (TB) exposed adult female G. holbrooki.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24074126 PMCID: PMC3852779 DOI: 10.1186/1471-2164-14-660
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
cDNA library sequencing and assembly results
| Total number of clean bases | 1,338,668,195 | Total number of bases | 67,321,337 |
| Number of fully assembled reads | 8,283,907 | Number of clean reads | 13,930,835 |
| Number of contigs | 162,704 | Number of contigs | 568,658 |
| Average contig size | 256.95 | Average contig size | 133.25 |
| Range of contig length | 100 – 3,413 | Range of contig length | 50 – 2,976 |
| | | ||
| Number of starting input sequences | 285,780 | ||
| Number of sequences kept after clean-up | 213,296 | ||
| Number of final assemblies | 165,062 | ||
| Number of gene hits with e-value ≤ 10-4 | 31,160 | ||
| Number of sequences with matches to | 27,505 | ||
| Number of sequences with matches to | 31,420 | ||
Figure 1Gene expression differences between the control and 17β-trenbolone (TB) exposed female . as determined by hierarchical cluster analysis. Genes with fold changes > 1.5 fold or < −1.5 fold over controls and with one-way ANOVA p-values < 0.05 were used for this analysis, and 279 genes were found to be down-regulated by TB exposure and 229 genes up-regulated by TB exposure. Data were median-centered by gene and clustered using centered correlation and complete linkage. Yellow genes are more highly expressed than the gene average and blue genes are expressed at a lower level than the gene average. The resulting gene expression map demonstrates the distinct hepatic expression profiles of the vehicle control-exposed and TB exposed groups.
Significantly differentially regulated biological processes during TB treatment as determined by gene set enrichment analysis
| go:0006629; lipid metabolic process | 0.002 | Enriched | 1.36% | 0.72% |
| go:0008380; rna splicing | 0.047 | Enriched | 1.18% | 0.76% |
| go:0015986; atp synthesis coupled proton transport | 0.001 | Enriched | 0.73% | 0.26% |
| go:0051246; regulation of protein metabolic process | 0.018 | Enriched | 0.47% | 0.17% |
| go:0051028; mrna transport | 0.025 | Enriched | 0.37% | 0.13% |
| go:0030168; platelet activation | 0.046 | Enriched | 0.36% | 0.15% |
| go:0032313; regulation of rab gtpase activity | 0.046 | Enriched | 0.36% | 0.15% |
| go:0042157; lipoprotein metabolic process | 0.0001 | Enriched | 0.35% | 0.02% |
| go:0006695; cholesterol biosynthetic process | 0.0005 | Enriched | 0.30% | 0.02% |
| go:0030301; cholesterol transport | 0.013 | Enriched | 0.24% | 0.04% |
| go:0008203; cholesterol metabolic process | 0.004 | Enriched | 0.18% | 0% |
| go:0033344; cholesterol efflux | 0.022 | Enriched | 0.18% | 0.02% |
| go:0045727; positive regulation of translation | 0.040 | Enriched | 0.16% | 0.02% |
| go:0006044; n-acetylglucosamine metabolic process | 0.032 | Enriched | 0.12% | 0% |
| go:0046677; response to antibiotics | 0.032 | Enriched | 0.12% | 0% |
a. The percent of transcripts in the GO category which were differentially regulated.
b. The percent of transcripts in the GO category which were not differentially regulated.
Figure 2Pathway analysis of hepatic genes differentially regulated by 17β-trenbolone: Impacts on metabolic pathways. Connections between significantly up or down-regulated genes in the liver and enriched Biological Processes from human homolog data were visualized. The red color represents up-regulation by TB and blue color represents down-regulation by TB compared to the samples exposed to the vehicle control. The intensity of the color is correlated with the degree of differential regulation. Red solid lines represent positive regulation of gene expression, blue solid lines represent negative regulation of gene expression, and grey solid lines represent unknown direction of regulation. Oval shapes represent individual genes and boxes represent GO Biological Processes. Gene abbreviations: COX2: cyclooxygenase II; CYBA: cytochrome b-245, alpha polypeptide; CYBB: cytochrome b-245, beta polypeptide; CYB5A: cytochrome b5 type A (microsomal); CYC1: cytochrome c-1;CYCS: cytochrome c, somatic; CYGB: cytoglobin; CYP(number)(letter)(number) for all entries: cytochrome P450, family number, subfamily letter, polypeptide variant number; DOCK2: dedicator of cytokinesis 2; EPX: eosinophil peroxidase; GUCY1B3: guanylate cyclase 1, soluble, beta 3;MB: myoglobin; MPO: myeloperoxidase; NOS1: nitric oxide synthase 1; NOX5: NADPH oxidase, EF-hand calcium binding domain 5; PRDX1: peroxiredoxin 1; SDHC: succinate dehydrogenase complex, subunit C, integral membrane protein, 15 kDa; TDO2: tryptophan 2,3-dioxygenase.
Follow-up qPCR of gene expression changes on selected genes
| 3.16 | 0.019 | 1.831 | 0.028 | |
| 3.05 | 0.032 | 1.860 | 0.188 | |
| 2.40 | 0.031 | 0.951 | 0.405 | |
| −1.32 | 0.033 | −0.486 | 0.505 | |
| −6.487 | 0.0001 | −7.6603 | <0.001 |